孤独症早期诊断生物学标记研究进展

吴梅荣 综述, 徐海青 审校

中国儿童保健杂志 ›› 2015, Vol. 23 ›› Issue (9) : 944-946.

PDF(475 KB)
PDF(475 KB)
中国儿童保健杂志 ›› 2015, Vol. 23 ›› Issue (9) : 944-946. DOI: 10.11852/zgetbjzz2015-23-09-15
综述与讲座

孤独症早期诊断生物学标记研究进展

  • 吴梅荣 综述, 徐海青 审校
作者信息 +
文章历史 +

摘要

孤独症谱系障碍是一类发病于婴幼儿期的严重的神经发育障碍,发病率逐年增加,该病特征为社会沟通和社会交往障碍及受限制、重复性模式的行为模式,但导致这些症状的病因不明,寻找导致病症的潜在生物标志物有助于了解孤独症的病理机制,并有助于对疾病的早期诊断及早期干预。国内外已经在寻找生物学标记物方面进行了一些研究,本文对此做一综述,并展望未来的发展。

关键词

孤独症 / 生物学标记 / 早期诊断

引用本文

导出引用
吴梅荣 综述, 徐海青 审校. 孤独症早期诊断生物学标记研究进展[J]. 中国儿童保健杂志. 2015, 23(9): 944-946 https://doi.org/10.11852/zgetbjzz2015-23-09-15
中图分类号: R749.94   

参考文献

[1] 万玉美,胡强,李婷,等.中国儿童孤独症谱系障碍患病率的系统综述[J].shanghai Archives of Psychiatry,2013,25(2):70-80.
[2] Verhoeven JS,De Cock P,Lagae L,et al.Neuroimaging of autism[J].Neuroradiology,2010,52(11):3-14.
[3] Perry EK,Lee ML,Martin-Ruiz CM,et al.Cholinergic activity in autism:abnormalities in the cerebral cortex and basal forebrain[J].Am J Psychiatry,2001,158(7):1058-1066.
[4] Laila Y,Avadhi AL.Relationship between sonic hedgehog protein,brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders[J].Neurochem Res,2012,37(2):394-400.
[5] 彭志晴,赵栋.孤独症儿童血清中脑源性神经营养因子的水平[J].中华疾病控制杂志,2014,18(1):1-4.
[6] 周家秀,郭兰婷,吴康敏,等.BDNF基因二核苷酸多态性与儿童孤独症的关联研究[J].中国实用儿科杂志,2006,21(12):933-935.
[7] 李家鑫,韦斌垣.BDNF 基因功能性多态rs6265 与孤独症儿童的相关性研究[J].中国现代医学杂志,2014,24(16):28-31.
[8] Kaether C,Haass C.A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation[J].J Cell Biol,2004,167(5):809-812.
[9] Bailey AR,Giunta BN,Obregon D,et al.Peripheral biomarkers in Autism:secreted amyloid precursor protein-α as a probable key player in early diagnosis[J].Int J Clin Exp Med,2008,1(4):338-344.
[10] Ray B,Long JM,Sokol DK.Increased secreted amyloid precursor protein-a (sAPPa) in severe autism:proposal of a specific,anabolic pathway and putative biomarker [J].PLoS ONE,2011,6(6):e20405.
[11] Al- Ayadhi LY,Ben Bacha AG,Kotb M,et al.A novel study on amyloid β peptide 40,42 and 40/42 ratio in Saudi autistics[J].Behavioral and Brain Functions,2012,8(1):4-6.
[12] Rossignol DA,Frye RE.The use of medications approved for Alzheimer's disease in autism spectrum disorder:a systematic review[J].Front Pediatr,2014,2(1):87.
[13] Gogolla N,Leblanc JJ,Quast KB,et al.Common circuit defect of excitatory-inhibitory balance in mouse models of autism[J].Neurodev Disord,2009,1(2):172-181.
[14] 何益群,赵靖平,寻广磊,等.儿童孤独症的血浆谷氨酸和γ2氨基丁酸水平及其与伴发癫痫的关系[J].Chin J Nerv Ment Dis,2009,35(9):526-529.
[15] Alabdali A,Al-Ayadhi L,El-Ansary A.Association of social and cognitive impairment and biomarkers in autism spectrum disorders[J].Journal of Neuroinflammation,2014,11(4):1-14.
[16] Andre A,Goldani S,Downs SR,et al.Biomarkers in autism[J].Frontiers in psychiatry,2014,5(110):1-13.
[17] Meneses A.5-HT systems:emergent targets for memory formation and memory alterations[J].Rev Neurosci,2013,24(6):629-664.
[18] 霍健,苏兴利,王爽.儿童孤独症多巴胺转运体脑显像研究[J].临床儿科杂志,2014,32(4):323-325.
[19] 韦斌垣,黄飞,覃小田.利培酮在治疗孤独症儿童行为问题中的作用[J].中国当代儿科杂志,2011,13(3):216-218.
[20] American Psychiatric Association.Diagnostic and statistical manual of mental disorders[M].5th ed.Washington,DC,American Psychiatric Association,2013.

基金

湖北省科技厅自然科学基金重点项目(2012FFA064)

PDF(475 KB)

Accesses

Citation

Detail

段落导航
相关文章

/